318 related articles for article (PubMed ID: 35258171)
1. Examining the psychometric properties of brief screening measures of depression and anxiety in chronic pain: The Patient Health Questionnaire 2-item and Generalized Anxiety Disorder 2-item.
Bisby MA; Karin E; Scott AJ; Dudeney J; Fisher A; Gandy M; Hathway T; Heriseanu AI; Staples L; Titov N; Dear BF
Pain Pract; 2022 Apr; 22(4):478-486. PubMed ID: 35258171
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of the Patient Health Questionnaire-4 scale and its subscales of depression and anxiety among US adults based on nativity.
Adzrago D; Walker TJ; Williams F
BMC Psychiatry; 2024 Mar; 24(1):213. PubMed ID: 38500115
[TBL] [Abstract][Full Text] [Related]
3. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6.
Staples LG; Dear BF; Gandy M; Fogliati V; Fogliati R; Karin E; Nielssen O; Titov N
Gen Hosp Psychiatry; 2019; 56():13-18. PubMed ID: 30508772
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7 in Lithuanian individuals with anxiety and mood disorders.
Stanyte A; Fineberg NA; Podlipskyte A; Gecaite-Stonciene J; Macijauskiene J; Steibliene V; Burkauskas J
J Psychiatr Res; 2023 Aug; 164():221-228. PubMed ID: 37385000
[TBL] [Abstract][Full Text] [Related]
5. Examination of the best cut-off points of PHQ-2 and GAD-2 for detecting depression and anxiety in Italian cardiovascular inpatients.
Giuliani M; Gorini A; Barbieri S; Veglia F; Tremoli E
Psychol Health; 2021 Sep; 36(9):1088-1101. PubMed ID: 33026888
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties and measurement invariance of the 7-item General Anxiety Disorder scale (GAD-7) in an Italian coronary heart disease population.
Bolgeo T; Di Matteo R; Simonelli N; Dal Molin A; Lusignani M; Bassola B; Vellone E; Maconi A; Iovino P
J Affect Disord; 2023 Aug; 334():213-219. PubMed ID: 37149049
[TBL] [Abstract][Full Text] [Related]
7. A computerized version of the Patient Health Questionnaire-4 as an ultra-brief screening tool to detect emotional disorders in primary care.
Cano-Vindel A; Muñoz-Navarro R; Medrano LA; Ruiz-Rodríguez P; González-Blanch C; Gómez-Castillo MD; Capafons A; Chacón F; Santolaya F;
J Affect Disord; 2018 Jul; 234():247-255. PubMed ID: 29549826
[TBL] [Abstract][Full Text] [Related]
8. Examining brief and ultra-brief anxiety and depression screening methods in a real-world epilepsy clinic sample.
Munger Clary HM; Wan M; Conner K; Brenes GA; Kimball J; Kim E; Duncan P; Snively BM
Epilepsy Behav; 2021 May; 118():107943. PubMed ID: 33839449
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Patient Health Questionnaire-4 (PHQ-4) to screen for depression and anxiety in the Greek general population.
Christodoulaki A; Baralou V; Konstantakopoulos G; Touloumi G
J Psychosom Res; 2022 Sep; 160():110970. PubMed ID: 35728338
[TBL] [Abstract][Full Text] [Related]
10. Detecting Depression and Anxiety Among Adolescents in South Africa: Validity of the isiXhosa Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7.
Marlow M; Skeen S; Grieve CM; Carvajal-Velez L; Åhs JW; Kohrt BA; Requejo J; Stewart J; Henry J; Goldstone D; Kara T; Tomlinson M
J Adolesc Health; 2023 Jan; 72(1S):S52-S60. PubMed ID: 36274021
[TBL] [Abstract][Full Text] [Related]
11. Validation of brief screening measures for depression and anxiety in young people with substance use disorders.
Bentley KH; Sakurai H; Lowman KL; Rines-Toth L; McKowen J; Pedrelli P; Evins AE; Yule AM
J Affect Disord; 2021 Mar; 282():1021-1029. PubMed ID: 33601674
[TBL] [Abstract][Full Text] [Related]
12. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population.
Löwe B; Wahl I; Rose M; Spitzer C; Glaesmer H; Wingenfeld K; Schneider A; Brähler E
J Affect Disord; 2010 Apr; 122(1-2):86-95. PubMed ID: 19616305
[TBL] [Abstract][Full Text] [Related]
13. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review.
Kroenke K; Spitzer RL; Williams JB; Löwe B
Gen Hosp Psychiatry; 2010; 32(4):345-59. PubMed ID: 20633738
[TBL] [Abstract][Full Text] [Related]
14. Equating the PHQ-9 and GAD-7 to the HADS depression and anxiety subscales in patients with major depressive disorder.
Huang XJ; Ma HY; Wang XM; Zhong J; Sheng DF; Xu MZ
J Affect Disord; 2022 Aug; 311():327-335. PubMed ID: 35598748
[TBL] [Abstract][Full Text] [Related]
15. The reliability and validity of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with infertility.
Maroufizadeh S; Omani-Samani R; Almasi-Hashiani A; Amini P; Sepidarkish M
Reprod Health; 2019 Sep; 16(1):137. PubMed ID: 31500644
[TBL] [Abstract][Full Text] [Related]
16. Update of the standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population.
Wicke FS; Krakau L; Löwe B; Beutel ME; Brähler E
J Affect Disord; 2022 Sep; 312():310-314. PubMed ID: 35760191
[TBL] [Abstract][Full Text] [Related]
17. Psychometric Validation of PHQ-9 and GAD-7 in Filipino Migrant Domestic Workers in Macao (SAR), China.
Garabiles MR; Lao CK; Yip P; Chan EWW; Mordeno I; Hall BJ
J Pers Assess; 2020; 102(6):833-844. PubMed ID: 31361153
[TBL] [Abstract][Full Text] [Related]
18. Validation of the patient health questionnaire-9 and the generalized anxiety disorder-7 in Lithuanian student sample.
Pranckeviciene A; Saudargiene A; Gecaite-Stonciene J; Liaugaudaite V; Griskova-Bulanova I; Simkute D; Naginiene R; Dainauskas LL; Ceidaite G; Burkauskas J
PLoS One; 2022; 17(1):e0263027. PubMed ID: 35085349
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of screening questionnaires to detect depression in primary healthcare setting in rural Ethiopia.
Habtamu K; Birhane R; Medhin G; Hanlon C; Fekadu A
BMC Prim Care; 2022 Jun; 23(1):138. PubMed ID: 35655164
[TBL] [Abstract][Full Text] [Related]
20. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome.
Snijkers JTW; van den Oever W; Weerts ZZRM; Vork L; Mujagic Z; Leue C; Hesselink MAM; Kruimel JW; Muris JWM; Bogie RMM; Masclee AAM; Jonkers DMAE; Keszthelyi D
Neurogastroenterol Motil; 2021 Dec; 33(12):e14161. PubMed ID: 33938601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
